Mon, Jul 01, 2024
According to sources, the US-headquartered PE company is set to pick up a 70 per cent stake in the hospital chain for around Rs 2,000 crore.
More >
Wed, Jun 19, 2024
Stock of the Day; Today Anil Singhvi gave buying advice in Gland Pharma, Sansera Eng & Indus Towers. What is stoploss and targets? See in this video.
Which shares will be in focus today - Vodafone Idea, Gland Pharma, WIPRO & Ixigo? Know the news related stocks and triggers in Stocks In News.
Wed, Nov 30, 2022
Gland Pharma Share Price NSE: Brokerages have given a mixed response on the stock post announcement of the agreement
Tue, Nov 29, 2022
Under the put option, an entity gets the right not obligation to sell a specified amount or stake at a predetermined price.
Why will Fosun Pharma sell stake? What is the big news for Gland Pharma? Why vigorous action in Gland Pharma? Know full details from Nupur.
Tue, Nov 01, 2022
According to Street, Gland Pharma reported a weak set of results in Q2FY23 with consolidated revenue declining by 3.3 per cent year-on-year (YoY) due to weak performance in geographies.
Sat, Oct 29, 2022
Global brokerage house are bullish on top 5 stocks for this week and give target price for investors. Here you know the stocks name and how to invest
Fri, Jan 21, 2022
The Hyderabad-based drug maker had reported a profit after tax (PAT) of Rs 204 crore in the corresponding period of the previous fiscal.
Fri, Dec 31, 2021
The benchmark indices have given over 20 per cent return in one year so far. The buying interest was broadly seen from all sectors.
Mon, Mar 01, 2021
Gland Pharma Limited (Gland) is an established player in the injectables space, which is one of the fastest-growing drug delivery formats across markets. Injectables are being preferred over oral delivery formats due to certain benefits offered such as convenience of administration.
Wed, Nov 18, 2020
The Initial Public Offer (IPO) of Rs 6500 cr of Gland Pharma received good response from the investors. The issue was subscribed by 2.06 times. The share of retail investors got subscribed 24%, while the share on non-institutional investors got subscribed 51%. The company had set a price band of Rs 1490 – Rs 1500 per share for the IPO.
Mon, Nov 09, 2020
Gland Pharma is a Fresh Issue of Equity shares aggregating up to Rs 1250 Cr and Offer for sale of up to 3.48 cr Equity Shares. The price band is in the range of Rs 1490 – Rs 1500 and the bid Lot is 10 Shares and in multiple thereof. Post Issue the implied market cap of the company will be Rs 24337 cr – 24492 cr.
Fri, Nov 06, 2020
Gland Pharma has an extensive track record in complex injectables development, manufacturing and marketing and a close understanding of the related sophisticated scientific, technical and regulatory processes.
Sun, Sep 17, 2017
Fosun Pharma has now agreed to reduce the size of the stake acquisition in India's Gland Pharma to 74% from 86% earlier.
Tue, Feb 21, 2017
The Foreign Investment Promotion Board (FIPB), headed by Economic Affairs Secretary Shaktikanta Das, has cleared 15 foreign investment proposals worth Rs 12,200 crore, which includes investments from Apollo Hospitals, Hindustan Aeronautics, Dr Reddy's and Vodafone.
Fri, Jul 29, 2016
The pharmaceutical arm of Chinese conglomerate Fosun plans to buy a majority stake in India`s Gland Pharma Ltd. for as much as $1.26 billion, in what is being touted as the biggest Indian acquisition by a Chinese company.
Mon, May 16, 2016
Shanghai Fosun said the proposal was made through its unit Fosun Industrial Co Ltd.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
